Track Kindred Biosciences's total assets ($110M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Kindred Biosciences (KIN) currently reports a total assets of $110M as of June 2021. That compares with $120M in the prior-year period — down 6.1% year over year. Use the charts on this page to explore Kindred Biosciences's total assets history and peer comparisons.
Kindred Biosciences's total assets decreased from $120M to $110M — a 6.1% year-over-year decrease (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Kindred Biosciences reported $110M in total assets as of June 2021. That compares with $120M in the prior-year period — down 6.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kindred Biosciences, and consider following KIN for alerts when major investors trade the stock.
Kindred Biosciences is classified in the Healthcare sector. On total assets, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KIN with unrelated industries.